The Next Decade of MPN Therapy: CALR Approaches, Novel Combinations, and the Evolution of Care with Dr. Lucia Masarova
Join HealthTree for MPN as Dr. Lucia Masarova explores the shift from symptom management to true disease modification through CALR-targeted therapies and novel combination regimens. This session provides a critical look at the next decade of MPN care, highlighting the latest data on deep molecular remissions and the emerging roles of novel therapies.
Dalton introduces the agenda of the event and featured speaker Dr. Lucia Masarova
Dr. Masarova talks about CARL therapy for MPN patients
Type your questions in the chat and we will answer them!
Dalton Bean
Dalton joined HealthTree in 2024 as the MPNs and MDS Program Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.
Lucia Masarova, MD
Dr. Lucia Masarova is an Assistant Professor at the Leukemia Department at the MD Anderson Cancer Center. Her clinical and research focus is on myeloproliferative neoplasms, and she is particularly interested in developing novel therapies to address the complex needs of MPN patients.